Cite
Benefit from prolonged dose-intensive chemotherapy for infants with malignant brain tumors is restricted to patients with ependymoma: a report of the Pediatric Oncology Group randomized controlled trial 9233/34.
MLA
Strother, Douglas R., et al. “Benefit from Prolonged Dose-Intensive Chemotherapy for Infants with Malignant Brain Tumors Is Restricted to Patients with Ependymoma: A Report of the Pediatric Oncology Group Randomized Controlled Trial 9233/34.” Neuro-Oncology, vol. 16, no. 3, Mar. 2014, pp. 457–65. EBSCOhost, https://doi.org/10.1093/neuonc/not163.
APA
Strother, D. R., Lafay-Cousin, L., Boyett, J. M., Burger, P., Aronin, P., Constine, L., Duffner, P., Kocak, M., Kun, L. E., Horowitz, M. E., & Gajjar, A. (2014). Benefit from prolonged dose-intensive chemotherapy for infants with malignant brain tumors is restricted to patients with ependymoma: a report of the Pediatric Oncology Group randomized controlled trial 9233/34. Neuro-Oncology, 16(3), 457–465. https://doi.org/10.1093/neuonc/not163
Chicago
Strother, Douglas R, Lucie Lafay-Cousin, James M Boyett, Peter Burger, Patricia Aronin, Louis Constine, Patricia Duffner, et al. 2014. “Benefit from Prolonged Dose-Intensive Chemotherapy for Infants with Malignant Brain Tumors Is Restricted to Patients with Ependymoma: A Report of the Pediatric Oncology Group Randomized Controlled Trial 9233/34.” Neuro-Oncology 16 (3): 457–65. doi:10.1093/neuonc/not163.